A carregar...
A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice
The use of C3d, the final degradation product of complement protein C3, as a “natural” adjuvant has been widely examined since the initial documentation of its immunogenicity-enhancing properties as a consequence of binding to complement receptor 2. Subsequently it was demonstrated that these effect...
Na minha lista:
| Publicado no: | Immunobiology |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849677/ https://ncbi.nlm.nih.gov/pubmed/29017821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imbio.2017.10.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|